The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study

INTRODUCTION: Exenatide is a new antidiabetic glucagon-like peptide-1 receptor agonist. In addition to its hypoglycemic effect, exenatide may have a potential protective benefit on vascular endothelial function. This study attempted to compare the effects of exenatide and traditional antidiabetic dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yanjin, Liu, Jia, Wang, Guang, Xu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984938/
https://www.ncbi.nlm.nih.gov/pubmed/29754323
http://dx.doi.org/10.1007/s13300-018-0435-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984938/
https://www.ncbi.nlm.nih.gov/pubmed/29754323
http://dx.doi.org/10.1007/s13300-018-0435-z

Ejemplares similares